Tuvik Beker

Tuvik Beker is an accomplished executive and technology expert with extensive experience in both leadership and innovation. Currently serving as Chief Executive Officer at Pangea Biomed, Tuvik Beker is instrumental in developing genetic interaction networks for cancer treatment. Concurrently, Tuvik Beker holds the position of Executive Chairman and Co-founder of MedAware, focusing on technology that enhances physician prescription safety. Previous roles include Founding Partner and Head of Research at Katros, Algorithmic Expert at myThings and TimeToKnow, and President and CEO of Soligence Corporation. Tuvik Beker's educational background includes a PhD in Computational Neuroscience from The Hebrew University of Jerusalem, alongside advanced studies in theoretical biology and executive leadership from esteemed universities such as Harvard and Stanford.